Stock Price
16.48
Daily Change
0.49%
Yearly
-12.53%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,037.00 14.00 0.46% -20.91%
Eisai 6,793.00 -67.00 -0.98% -11.66%
Acadia Pharmaceuticals 19.94 1.04 5.50% -62.58%
Agios Pharmaceuticals 34.83 -0.21 -0.60% -23.03%
Akebia Therapeutics 2.67 0.10 3.89% -12.75%
Amgen 201.17 0.37 0.18% -11.34%
AstraZeneca 8,231.00 -83.00 -1.00% 6.50%
Bayer 44.94 -0.44 -0.96% -5.89%
Bluebird Bio 10.63 0.58 5.77% -77.37%
BioMarin Pharmaceutical 84.68 0.18 0.21% 7.05%
Bristol-Myers Squibb 55.41 0.46 0.84% -10.31%
Cytokinetics 38.15 1.24 3.36% 118.50%
Dicerna Pharmaceuticals 38.12 0.02 0.05% 54.33%
Esperion Therapeutics 8.97 0.93 11.57% -69.59%
Exelixis 16.48 0.08 0.49% -12.53%
Genmab 2,536.00 -21.00 -0.82% 7.32%
Glaxosmithkline 41.47 0.12 0.28% 11.27%
Immunogen 7.16 0.39 5.76% 23.13%
Incyte Corp 66.63 1.67 2.57% -19.63%
Ionis Pharmaceuticals 25.61 -0.89 -3.36% -49.90%
Eli Lilly 247.88 -1.25 -0.50% 72.01%
MacroGenics 17.33 0.72 4.33% -23.28%
Merck & Co 73.89 -0.55 -0.74% -9.28%
Moderna Inc 301.49 -9.12 -2.94% 91.71%
Mirati Therapeutics 137.06 5.02 3.80% -40.80%
Neurocrine Biosciences 80.64 -0.15 -0.19% -18.36%
Nektar Therapeutics 11.41 0.21 1.88% -33.16%
Novartis 73.80 -0.44 -0.59% -8.80%
Puma Biotechnology 3.01 0.01 0.33% -75.19%
Pfizer 53.04 -1.64 -3.00% 32.30%
Ultragenyx Pharmaceutical 79.12 2.96 3.89% -36.27%
Seattle Genetics 158.67 0.42 0.27% -11.93%
Sanofi 47.69 -0.43 -0.88% -4.83%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%
Xencor 36.73 1.05 2.94% -5.34%

Indexes Price Day Year
US2000 2206 58.91 2.74% 19.35%
NASDAQ 15381 127.27 0.83% 24.27%
US400 2737 72.77 2.73% 24.23%

Exelixis
Exelixis, Inc. is an oncology focused biotechnology company. The Company is engaged in the discovery, development and commercialization of medicines to treat cancers. Its platform also provides therapies to cancer patients with additional treatment options. The Company's cabozantinib molecule, is an inhibitor of multiple tyrosine kinases including MET, AXL, VEGF receptors and RET. The products derived from cabozantinib are CABOMETYX tablets for renal cell carcinoma (RCC) and COMETRIQ capsules for progressive, metastatic medullary thyroid cancer (MTC). Its other two product candidates are COTELLIC (cobimetinib), is an inhibitor of MEK with multiple combination regimens to treat specific forms of advanced melanoma and MINNEBRO (esaxerenone), is an oral, non-steroidal, selective blocker of the mineralocorticoid receptor (MR) for the treatment of hypertension. Its phase I b clinical trial programs include XL092, STELLAR-001 and STELLAR-002.